Tu2024 VOLIXIBAT LEADS TO IMPROVEMENTS IN FATIGUE AND SLEEP FOR ADULTS WITH PRIMARY BILIARY CHOLANGITIS: DATA FROM VANTAGE
Mitchell L. Shiffman, Debra Weinstein, Victor Ankoma-Sey, Nimer Assy et autres
0 citations
Gastroenterology
Joanne Quan
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
5Publications signalées
1Citations signalées
0Affiliations récentes
Les domaines associés
Gastroesophageal reflux and treatmentsInflammatory Bowel DiseaseInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisDysphagia Assessment and ManagementDental Erosion and Treatment
Les publications récentes
Tu2023 EXPLORING THE ROLE OF VOLIXIBAT, AN ILEAL BILE ACID TRANSPORTER INHIBITOR, IN THE REGULATION OF IL-31 AND SERUM BILE ACIDS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: PRELIMINARY RESULTS FROM THE VANTAGE TRIAL
Mitchell L. Shiffman, Alan Bonder, Debra Weinstein, Victor Ankoma-Sey et autres
0 citations
Gastrointestinal Endoscopy
Tu2023 EXPLORING THE ROLE OF VOLIXIBAT, AN ILEAL BILE ACID TRANSPORTER INHIBITOR, IN THE REGULATION OF IL-31 AND SERUM BILE ACIDS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: PRELIMINARY RESULTS FROM THE VANTAGE TRIAL
Mitchell L. Shiffman, Alan Bonder, Debra Weinstein, Victor Ankoma-Sey et autres
0 citations
Gastroenterology
Tu2024 VOLIXIBAT LEADS TO IMPROVEMENTS IN FATIGUE AND SLEEP FOR ADULTS WITH PRIMARY BILIARY CHOLANGITIS: DATA FROM VANTAGE
Mitchell L. Shiffman, Debra Weinstein, Victor Ankoma-Sey, Nimer Assy et autres
0 citations
Gastrointestinal Endoscopy
LBO-006 Efficacy and safety of volixibat, an IBAT inhibitor, in patients with primary sclerosing cholangitis and moderate-to-severe pruritus: results of the VISTAS trial
Cynthia Levy, Gideon M. Hirschfield, Mitchell Shiffman, Muyiwa Awoniyi et autres
1 citation
Journal of Hepatology
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.